ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 66 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $201,958 | -13.6% | 4,994 | -0.6% | 0.00% | – |
Q4 2022 | $233,763 | -24.3% | 5,025 | -15.9% | 0.00% | – |
Q3 2022 | $309,000 | +50.0% | 5,977 | +116.5% | 0.00% | – |
Q4 2021 | $206,000 | -99.3% | 2,761 | -99.0% | 0.00% | -100.0% |
Q2 2018 | $31,064,000 | +34.3% | 268,025 | -6.2% | 0.02% | +33.3% |
Q1 2018 | $23,124,000 | +24.0% | 285,800 | -10.0% | 0.01% | +33.3% |
Q4 2017 | $18,643,000 | +99.2% | 317,700 | +58.8% | 0.01% | +80.0% |
Q3 2017 | $9,360,000 | +14.7% | 200,000 | -33.1% | 0.01% | +25.0% |
Q4 2013 | $8,157,000 | -32.9% | 299,000 | -43.7% | 0.00% | -33.3% |
Q3 2013 | $12,164,000 | +43.1% | 530,700 | +10.6% | 0.01% | +20.0% |
Q2 2013 | $8,499,000 | – | 479,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |